Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A prion protein expression inhibitor is a molecule or agent that reduces the synthesis or accumulation of the cellular prion protein (PrP^C), which is encoded by the PRNP gene. The misfolding and aggregation of PrP^C into its pathogenic form (PrP^Sc) underlies prion diseases, a group of fatal neurodegenerative disorders including Creutzfeldt–Jakob disease (CJD) and scrapie. Inhibiting prion protein expression or its pathological conversion is considered a promising therapeutic strategy for these diseases.
Transcriptional repression, destabilization/folding inhibition, endocytosis/degradation of PrP^C
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prion Protein Expression Inhibitor.